At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Roux-en-Y gastric bypass (RYGB) (procedure)
- How long the study runs
- Study runs about 120 months (dates as stated)
- About the drug or intervention
- Roux-en-Y gastric bypass (RYGB) — procedure: Bariatric surgery
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years to 80 Years
- Who
- All
- Number of participants
- 210
- Started
- 2018-10-01
- Last checked
- 2023-04
Plain English Summary
What is this study?
- • Testing a new treatment for diabetes mellitus, type 2
- • Clinical study - 210 participants
- • A study investigating the influence of fat distribution, genetic susceptibility markers for type 2 diabetes (T2DM) and fat distribution, epigenetic and transcriptomic changes and gut hormone responses to a mixed meal on diabetes remission following bariatric surgery
Who can take part?
- • Ages 18 Years to 80 Years
- • Diagnosed with diabetes mellitus, type 2
Where?
- • London - Imperial College Healthcare NHS Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
A study investigating the influence of fat distribution, genetic susceptibility markers for type 2 diabetes (T2DM) and fat distribution, epigenetic and transcriptomic changes and gut hormone responses to a mixed meal on diabetes remission following bariatric surgery.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years - 80 Years
- Who can join: All genders
What the study is looking for
- ✓Males and females planning to undergo RYGB
- ✓18-80 years
- ✓Type 2 diabetes mellitus or prediabetes
- ✓Stable weight for at least 3 months
- ✓Obese (BMI ≥30kg/m2)
Who cannot take part
- ✗Current pregnancy
- ✗Inability to give agreement to take part
- ✗Type 1 diabetes
- ✗Low fasting C-peptide
- ✗Secondary diabetes or absence of β-cell function
See the full criteria
Where Is This Study? (1 UK site)
Imperial College Healthcare NHS Trust
London W12 0HS, United Kingdom
How to Get in Touch
Julia S Kenkre, MB BChir
Sponsor contactCONTACT
